Table 4. Prescription duration and posology of BMV plaster according to skin disease.
| Enrolled patients N = 258 |
||||
|---|---|---|---|---|
| Eczema N = 87 | Psoriasis N = 125 | Other dermatoses N = 45 | Total N = 258* | |
| Prescription duration (day) | ||||
| N | 87 (100.0%) | 123 (98.4%) | 44 (97.8%) | 254 (98.5%) |
| m ± SD | 18.7 ± 9.1 | 24.1 ± 7.7 | 26.5 ± 8.0 | 22.7 ± 8.8 |
| [min–max; med] | [7–31; 15] | [6–31; 30] | [7–60; 30] | [6–60; 28] |
| Posology (plaster/day) | ||||
| N | 84 (96.6%) | 122 (97.6%) | 45 (100.0%) | 251 (97.3%) |
| m ± SD | 1.9 ± 1.2 | 2.6 ± 1.4 | 1.9 ± 1.1 | 2.2 ± 1.3 |
| [min–max; med] | [1–6; 2] | [1–6; 2] | [1–5; 2] | [1–6; 2] |
| Number of plaster/day: | ||||
| 1 N (%) | 41 (48.8%) | 35 (28.7%) | 21 (46.7%) | 97 (38.7%) |
| 2 N (%) | 27 (32.1%) | 35 (28.7%) | 13 (28.9%) | 75 (29.9%) |
| 3 N (%) | 3 (3.6%) | 12 (9.8%) | 6 (13.3%) | 21 (8.4%) |
| 4 N (%) | 9 (10.7%) | 33 (27.1%) | 4 (8.9%) | 46 (18.3%) |
| 5 N (%) | 3 (3.6%) | 2 (1.6%) | 1 (2.2%) | 6 (2.4%) |
| 6 N (%) | 1 (1.2%) | 5 (4.1%) | 0 (0.0%) | 6 (2.4%) |
| ND | 3 | 3 | – | 7* |
*For 1 patient, the CRF has not been returned.